Skip to content
AnalystLens

CME GROUP INC. 8-K Report, Financial Results (Apr 24, 2024)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed April 24, 2024
Period End
April 24, 2024
Security
CME
In the record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’17Nov ’17
  2. Leadership change8-K · Feb ’20Feb ’20
  3. Material agreement8-K · Apr ’22Apr ’22
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed April 24, 2024. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. (CME) filed an 8-K on April 24, 2024, to report its financial results for the quarter ended March 31, 2024.

The core of the filing is the incorporation by reference of a press release (Exhibit 99.1) detailing these quarterly results. Investors should note that this press release includes both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures. The company highlights the use of non-GAAP net income and earnings per share, stating that management believes these provide valuable supplemental information for understanding financial and business trends and offer better comparability with prior periods.

While these non-GAAP measures are presented as supplements, the filing emphasizes that they should not be considered a substitute for or superior to the GAAP-based figures. A reconciliation between the non-GAAP and GAAP measures is included in the press release.

Key Highlights

  1. CME Group Inc. reported its Q1 2024 financial results via an 8-K filing on April 24, 2024.
  2. The filing incorporates by reference a press release dated April 24, 2024, containing the detailed financial results.
  3. The press release includes both GAAP and non-GAAP financial measures, such as non-GAAP net income and earnings per share.
  4. Management views non-GAAP measures as important for supplemental information and comparability with prior periods.
  5. The company acknowledges that non-GAAP adjustments may include recurring items.
  6. A reconciliation of non-GAAP to GAAP financial measures is provided within the press release.
  7. Information furnished under Item 2.02 is not considered 'filed' for certain regulatory purposes unless expressly incorporated by reference in other filings.

Frequently Asked Questions

  1. What is the main purpose of this 8-K filing?

    The main purpose of this 8-K filing is to formally report CME Group Inc.'s financial results for the quarter ended March 31, 2024, by incorporating a press release that contains these results.

  2. Does the filing provide new financial figures directly, or does it reference another document?

    The filing primarily references and incorporates by reference a press release (Exhibit 99.1) dated April 24, 2024, which contains the detailed financial figures and discussion for the quarter.

  3. What is the significance of the non-GAAP financial measures mentioned?

    The non-GAAP financial measures (like non-GAAP net income and EPS) are presented by CME Group to offer supplemental insights into financial trends and improve comparability with historical performance. However, they are supplementary and should not replace the primary GAAP-based financial reporting.

  4. Where can investors find the reconciliation between GAAP and non-GAAP figures?

    The reconciliation between the non-GAAP financial measures and the most directly comparable GAAP financial measures is included within the press release itself, which is attached as Exhibit 99.1 to the 8-K filing.